【Goldman Sachs】【20221009】Rhythm Pharmaceuticals (RYTM) Full Ph2 results to support development strategy in HO-10页

Goldman Sachs 公共管理社会组织 2022年 PDF 2.03 MB

Imcivree pharmaceuticals hypothalamic obesity phase 2 results clinical trial